With Democrats pushing to upend US health care and create a single-payer system, the Congressional Budget Office (CBO) on Wednesday offered a look at how such a system would pay for pharmaceuticals, while keeping in mind the trade-offs and the impact on pharmaceutical manufacturers’ research and development.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,